Search Results

Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

• Source: PLOS ONE ; volume 19, issue 2, page e0299822 ; ISSN 1932-6203

Record details

Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study

• Authors : Chen, Wei-Cheng; Li, Jian-Ri; Wang, Shian-Shiang ...

• Source: PLOS ONE ; volume 18, issue 1, page e0279981 ; ISSN 1932-6203

Record details

Gaining metabolic insight in older men undergoing androgen deprivation therapy for prostate cancer (the ADT & Metabolism Study): Protocol of a longitudinal, observational, cohort study

• Authors : Braga-Basaria, Milena; Travison, Thomas G.; Taplin, Mary-Ellen ...

• Source: PLOS ONE ; volume 18, issue 2, page e0281508 ; ISSN 1932-6203

Record details

The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis

• Authors : Shao, Wenjuan; Zhang, Hanyue; Qi, Han ...

• Source: PLOS ONE ; volume 17, issue 2, page e0263918 ; ISSN 1932-6203

Record details

Social cognitive outcomes are associated with improvements in mobility performance following lifestyle intervention in prostate cancer patients undergoing androgen deprivation therapy

• Authors : Chaplow, Zachary L.; Lucas, Alexander R.; Grainger, Elizabeth ...

• Source: PLOS ONE ; volume 17, issue 1, page e0263136 ; ISSN 1932-6203

Record details

Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone

• Authors : Kanao, Kent; Takahashi, Takayuki; Umezawa, Yuta ...

• Source: PLOS ONE ; volume 17, issue 10, page e0276081 ; ISSN 1932-6203

Record details

Conventional androgen deprivation therapy is associated with an increased risk of cardiovascular disease in advanced prostate cancer, a nationwide population-based study

• Authors : Li, Jian-Ri; Wang, Shian-Shiang; Chen, Chuan-Shu ...

• Source: PLOS ONE ; volume 17, issue 6, page e0270292 ; ISSN 1932-6203

Record details

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic

• Authors : Gedeborg, Rolf; Styrke, Johan; Loeb, Stacy ...

• Source: PLOS ONE ; volume 16, issue 10, page e0255966 ; ISSN 1932-6203

Record details

Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer

• Authors : Jeong, Jae-Uk; Nam, Taek-Keun; Song, Ju-Young ...

• Source: PLOS ONE ; volume 16, issue 3, page e0248461 ; ISSN 1932-6203

Record details

Risk of dementia and Parkinson’s disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study

• Authors : Shim, Myungsun; Bang, Woo Jin; Oh, Cheol Young ...

• Source: PLOS ONE ; volume 15, issue 12, page e0244660 ; ISSN 1932-6203

Record details